manufacturing news from FierceBioResearcher
NewsFDA suspends GMP requirements on trial drugs
The FDA has issued new guidelines that exempt Phase I drugs from certain Good Manufacturing Practice regulations. In issuing the exemptions - which go into effect September 15, the agency notes that Read more...
Novartis bankrolls a drug manufacturing revolution
With the help of a $65 million contribution from Novartis, scientists at MIT are launching a 10-year program aimed at revolutionizing the way drugs are manufactured. At the heart of the project is Read more...
| Press ReleasesPRESS RELEASE: Amgen to postpone indefinitely plans for a manufacturing facility in Ireland AMGEN TO POSTPONE INDEFINITELY ITS PLANS FOR A MANUFACTURING FACILITY IN IRELAND CORK, IRELAND (Oct. 3, 2007) Amgen today announced that following an updated review of its business plans, concurrent Read more... |
Get more manufacturing coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets